BRAF c.2221G>C ;(p.E741Q)

Variant ID: 7-140434477-C-G

NM_004333.4(BRAF):c.2221G>C;(p.E741Q)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Case Report: Significant Response to Immune Checkpoint Inhibitor Camrelizumab in a Heavily Pretreated Advanced ER+/HER2- Breast Cancer Patient With High Tumor Mutational Burden.

Frontiers In Oncology
Wang, Rong R; Yang, Yuchen Y; Ye, Wei-Wu WW; Xiang, Jianxing J; Chen, Songan S; Zou, Wei-Bin WB; Wang, Xiao-Jia XJ; Chen, Tianhui T; Cao, Wen-Ming WM
Publication Date: 2020

Variant appearance in text: BRAF: 2221G>C; E741Q
PubMed Link: 33634015
Variant Present in the following documents:
  • Table_1.xlsx, sheet 8
  • Table_1.xlsx, sheet 5
  • Table_1.xlsx, sheet 7
View BVdb publication page